Regulation of USP7: A High Incidence of E3 Complexes

Journal of Molecular Biology

Volumn 429, Issue 22, 2017, Pages 3395-3408

  Kim, Robbert Q ^a   Sixma, Titia K ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

activity modulation; molecular switches; USP7

Indexed keywords

BRCA1 PROTEIN; BRCA1 PROTEIN BRCA1 A; DEUBIQUITINASE; DNA; DNA METHYLTRANSFERASE 1; ENZYME INHIBITOR; GMP SYNTHETASE; GUANOSINE PHOSPHATE; MULTIENZYME COMPLEX; MULTIENZYME COMPLEX BRISC; POLYCOMB GROUP PROTEIN; PROTEIN MDM2; PROTEIN P53; REGULATOR PROTEIN; SYNTHETASE; TRIPARTITE MOTIF PROTEIN; TRIPARTITE MOTIF PROTEIN TRIM27; UBIQUITIN PROTEIN LIGASE E3; UBIQUITIN PROTEIN LIGASE E3 UHRF1; UBIQUITIN SPECIFIC PROTEASE 7; UNCLASSIFIED DRUG; VIRUS ENZYME; UBIQUITIN THIOLESTERASE;

CARBOXY TERMINAL SEQUENCE; COMPLEX FORMATION; CYTOPLASM; DNA DAMAGE; DNA REPAIR; ENZYME ACTIVATION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME REGULATION; ENZYME STRUCTURE; ENZYME SUBSTRATE COMPLEX; HUMAN; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION; UBIQUITINATION; ENZYMOLOGY; EUKARYOTIC CELL; METABOLISM; PROTEIN FOLDING; PROTEIN MULTIMERIZATION;

EUKARYOTIC CELLS; MULTIENZYME COMPLEXES; PROTEIN FOLDING; PROTEIN MULTIMERIZATION; UBIQUITIN THIOLESTERASE;

EID: 85020802132     PISSN: 00222836     EISSN: 10898638     Source Type: Journal    
DOI: 10.1016/j.jmb.2017.05.028     Document Type: Review

References (116)

1. Pickart, C.M., Eddins, M.J., Ubiquitin: structures, functions, mechanisms. Biochim. Biophys. Acta 1695 (2004), 55–72, 10.1016/j.bbamcr.2004.09.019.
2. Komander, D., Rape, M., The ubiquitin code. Annu. Rev. Biochem. 81 (2012), 203–229, 10.1146/annurev-biochem-060310-170328.
3. Pickart, C.M., Ubiquitin in chains. Trends Biochem. Sci. 25 (2000), 544–548.
4. Clague, M.J., Barsukov, I., Coulson, J.M., Liu, H., Rigden, D.J., Urbe, S., Deubiquitylases from genes to organism. Physiol. Rev. 93 (2013), 1289–1315, 10.1152/physrev.00002.2013.
5. Komander, D., Clague, M.J., Urbé, S., Breaking the chains: structure and function of the deubiquitinases. Nat. Rev. Mol. Cell Biol. 10 (2009), 550–563, 10.1038/nrm2731.
6. Sahtoe, D.D., Sixma, T.K., Layers of DUB regulation. Trends Biochem. Sci. 40 (2015), 456–467, 10.1016/j.tibs.2015.05.002.
7. Nijman, S.M.B., Luna-Vargas, M.P.A., Velds, A., Brummelkamp, T.R., Dirac, A.M.G., Sixma, T.K., Bernards, R., A genomic and functional inventory of deubiquitinating enzymes. Cell 123 (2005), 773–786, 10.1016/j.cell.2005.11.007.
8. Sowa, M.E., Bennett, E.J., Gygi, S.P., Harper, J.W., Defining the human deubiquitinating enzyme interaction landscape. Cell 138 (2009), 389–403, 10.1016/j.cell.2009.04.042.
9. Kessler, B.M., Fortunati, E., Melis, M., Pals, C.E.G.M., Clevers, H., Maurice, M.M., Proteome changes induced by knock-down of the deubiquitylating enzyme HAUSP/USP7. J. Proteome Res. 6 (2007), 4163–4172, 10.1021/pr0702161.
10. Cummins, J.M., Vogelstein, B., HAUSP is required for p53 destabilization. Cell Cycle 3 (2004), 689–692.
11. McClurg, U.L., Robson, C.N., Deubiquitinating enzymes as oncotargets. Oncotarget 6 (2015), 9657–9668, 10.18632/oncotarget.3922.
12. Lecona, E., Rodriguez-Acebes, S., Specks, J., Lopez-Contreras, A.J., Ruppen, I., Murga, M., Muñoz, J., Mendez, J., Fernandez-Capetillo, O., USP7 is a SUMO deubiquitinase essential for DNA replication. Nat. Struct. Mol. Biol. 23 (2016), 270–277, 10.1038/nsmb.3185.
13. Hao, Y.-H., Fountain, M.D., Fon Tacer, K., Xia, F., Bi, W., Kang, S.-H.L., Patel, A., Rosenfeld, J.A., Le Caignec, C., Isidor, B., Krantz, I.D., Noon, S.E., Pfotenhauer, J.P., Morgan, T.M., Moran, R., Pedersen, R.C., Saenz, M.S., Schaaf, C.P., Potts, P.R., USP7 acts as a molecular rheostat to promote WASH-dependent endosomal protein recycling and is mutated in a human neurodevelopmental disorder. Mol. Cell 59 (2015), 956–969, 10.1016/j.molcel.2015.07.033.
14. Kon, N., Kobayashi, Y., Li, M., Brooks, C.L., Ludwig, T., Gu, W., Inactivation of HAUSP in vivo modulates p53 function. Oncogene 29 (2010), 1270–1279, 10.1038/onc.2009.427.
15. Kon, N., Zhong, J., Kobayashi, Y., Li, M., Szabolcs, M., Ludwig, T., Canoll, P.D., Gu, W., Roles of HAUSP-mediated p53 regulation in central nervous system development. Cell Death Differ. 18 (2011), 1366–1375, 10.1038/cdd.2011.12.
16. Faesen, A.C., Dirac, A.M.G., Shanmugham, A., Ovaa, H., Perrakis, A., Sixma, T.K., Mechanism of USP7/HAUSP activation by its C-terminal ubiquitin-like domain and allosteric regulation by GMP-synthetase. Mol. Cell 44 (2011), 147–159, 10.1016/j.molcel.2011.06.034.
17. Fernández-Montalván, A., Bouwmeester, T., Joberty, G., Mader, R., Mahnke, M., Pierrat, B., Schlaeppi, J.-M., Worpenberg, S., Gerhartz, B., Biochemical characterization of USP7 reveals post-translational modification sites and structural requirements for substrate processing and subcellular localization. FEBS J. 274 (2007), 4256–4270, 10.1111/j.1742-4658.2007.05952.x.
18. Pang, C.N.I., Hayen, A., Wilkins, M.R., Surface accessibility of protein post-translational modifications. J. Proteome Res. 6 (2007), 1833–1845, 10.1021/pr060674u.
19. Hu, M., Li, P., Li, M., Li, W., Yao, T., Wu, J.-W., Gu, W., Cohen, R.E., Shi, Y., Crystal structure of a UBP-family deubiquitinating enzyme in isolation and in complex with ubiquitin aldehyde. Cell 111 (2002), 1041–1054.
20. Zhu, X., Ménard, R., Sulea, T., High incidence of ubiquitin-like domains in human ubiquitin-specific proteases. Proteins 69 (2007), 1–7, 10.1002/prot.21546.
21. Rougé, L., Bainbridge, T.W., Kwok, M., Tong, R., Di Lello, P., Wertz, I.E., Maurer, T., Ernst, J.A., Murray, J., Molecular understanding of USP7 substrate recognition and C-terminal activation. Structure 24 (2016), 1335–1345, 10.1016/j.str.2016.05.020.
22. Kim, R.Q., van Dijk, W.J., Sixma, T.K., Structure of USP7 catalytic domain and three Ubl-domains reveals a connector α-helix with regulatory role. J. Struct. Biol. 195 (2016), 11–18, 10.1016/j.jsb.2016.05.005.
23. Sheng, Y., Saridakis, V., Sarkari, F., Duan, S., Wu, T., Arrowsmith, C.H., Frappier, L., Molecular recognition of p53 and MDM2 by USP7/HAUSP. Nat. Struct. Mol. Biol. 13 (2006), 285–291, 10.1038/nsmb1067.
24. Hu, M., Gu, L., Li, M., Jeffrey, P.D., Gu, W., Shi, Y., Structural basis of competitive recognition of p53 and MDM2 by HAUSP/USP7: implications for the regulation of the p53-MDM2 pathway. PLoS Biol., 4, 2006, e27, 10.1371/journal.pbio.0040027.
25. Jagannathan, M., Nguyen, T., Gallo, D., Luthra, N., Brown, G.W., Saridakis, V., Frappier, L., A role for USP7 in DNA replication. Mol. Cell. Biol. 34 (2014), 132–145, 10.1128/MCB.00639-13.
26. Ye, H., Park, Y.C., Kreishman, M., Kieff, E., Wu, H., The structural basis for the recognition of diverse receptor sequences by TRAF2. Mol. Cell 4 (1999), 321–330.
27. Saridakis, V., Sheng, Y., Sarkari, F., Holowaty, M.N., Shire, K., Nguyen, T., Zhang, R.G., Liao, J., Lee, W., Edwards, A.M., Arrowsmith, C.H., Frappier, L., Structure of the p53 binding domain of HAUSP/USP7 bound to Epstein–Barr nuclear antigen 1 implications for EBV-mediated immortalization. Mol. Cell 18 (2005), 25–36, 10.1016/j.molcel.2005.02.029.
28. Sarkari, F., Wheaton, K., La Delfa, A., Mohamed, M., Shaikh, F., Khatun, R., Arrowsmith, C.H., Frappier, L., Saridakis, V., Sheng, Y., USP7/HAUSP is a regulator of UbE2E1/UbcH6. J. Biol. Chem. 288 (2013), 16975–16985, 10.1074/jbc.M113.469262.
29. Zapata, J.M., Pawlowski, K., Haas, E., Ware, C.F., Godzik, A., Reed, J.C., A diverse family of proteins containing tumor necrosis factor receptor-associated factor domains. J. Biol. Chem. 276 (2001), 24,242–24,252, 10.1074/jbc.M100354200.
30. Vijay-Kumar, S., Bugg, C.E., Cook, W.J., Structure of ubiquitin refined at 1.8 A resolution. J. Mol. Biol. 194 (1987), 531–544.
31. Kiel, C., Serrano, L., The ubiquitin domain superfold: structure-based sequence alignments and characterization of binding epitopes. J. Mol. Biol. 355 (2006), 821–844, 10.1016/j.jmb.2005.10.010.
32. Faesen, A.C., Luna-Vargas, M.P.A., Sixma, T.K., The role of UBL domains in ubiquitin-specific proteases. Biochem. Soc. Trans. 40 (2012), 539–545, 10.1042/BST20120004.
33. Clerici, M., Luna-Vargas, M.P.A., Faesen, A.C., Sixma, T.K., The DUSP-Ubl domain of USP4 enhances its catalytic efficiency by promoting ubiquitin exchange. Nat. Commun., 5, 2014, 5399, 10.1038/ncomms6399.
34. Pfoh, R., Lacdao, I.K., Georges, A.A., Capar, A., Zheng, H., Frappier, L., Saridakis, V., Crystal structure of USP7 ubiquitin-like domains with an ICP0 peptide reveals a novel mechanism used by viral and cellular proteins to target USP7. PLoS Pathog., 11, 2015, e1004950, 10.1371/journal.ppat.1004950.
35. Cheng, J., Yang, H., Fang, J., Ma, L., Gong, R., Wang, P., Li, Z., Xu, Y., Molecular mechanism for USP7-mediated DNMT1 stabilization by acetylation. Nat. Commun., 6, 2015, 7023, 10.1038/ncomms8023.
36. Zhang, Z.-M., Rothbart, S.B., Allison, D.F., Cai, Q., Harrison, J.S., Li, L., Wang, Y., Strahl, B.D., Wang, G.G., Song, J., An allosteric interaction links USP7 to deubiquitination and chromatin targeting of UHRF1. Cell Rep. 12 (2015), 1400–1406, 10.1016/j.celrep.2015.07.046.
37. Cheng, J., Li, Z., Gong, R., Fang, J., Yang, Y., Sun, C., Yang, H., Xu, Y., Molecular mechanism for the substrate recognition of USP7. Protein Cell 6 (2015), 849–852, 10.1007/s13238-015-0192-y.
38. Wu, H.-T., Kuo, Y.-C., Hung, J.-J., Huang, C.-H., Chen, W.-Y., Chou, T.-Y., Chen, Y.-J.Y.Y.-J., Chen, Y.-J.Y.Y.-J., Chen, Y.-J.Y.Y.-J., Cheng, W.-C., Teng, S.-C., Wu, K.-J., K63-polyubiquitinated HAUSP deubiquitinates HIF-1α and dictates H3K56 acetylation promoting hypoxia-induced tumour progression. Nat. Commun., 7, 2016, 13,644, 10.1038/ncomms13644.
39. Zaman, M.M.-U., Nomura, T., Takagi, T., Okamura, T., Jin, W., Shinagawa, T., Tanaka, Y., Ishii, S., Ubiquitination-deubiquitination by the TRIM27–USP7 complex regulates TNF-α-induced apoptosis. Mol. Cell. Biol. 33 (2013), 4971–4984, 10.1128/MCB.00465-13.
40. Choudhary, C., Kumar, C., Gnad, F., Nielsen, M.L., Rehman, M., Walther, T.C., Olsen, J.V., Mann, M., Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 325 (2009), 834–840, 10.1126/science.1175371.
41. Prives, C., Signaling to p53: breaking the MDM2-p53 circuit. Cell 95 (1998), 5–8.
42. Joerger, A.C., Fersht, A.R., Structural biology of the tumor suppressor p53. Annu. Rev. Biochem. 77 (2008), 557–582, 10.1146/annurev.biochem.77.060806.091238.
43. Li, M., Brooks, C.L., Kon, N., Gu, W., A dynamic role of HAUSP in the p53-Mdm2 pathway. Mol. Cell 13 (2004), 879–886.
44. Cummins, J.M., Rago, C., Kohli, M., Kinzler, K.W., Lengauer, C., Vogelstein, B., Tumour suppression: disruption of HAUSP gene stabilizes p53. Nature 428 (2004), 486–487, 10.1038/nature02501.
45. Tang, J., Qu, L.-K., Zhang, J., Wang, W., Michaelson, J.S., Degenhardt, Y.Y., El-Deiry, W.S., Yang, X., Critical role for Daxx in regulating Mdm2. Nat. Cell Biol. 8 (2006), 855–862, 10.1038/ncb1442.
46. Nihira, N.T., Ogura, K., Shimizu, K., North, B.J., Zhang, J., Gao, D., Inuzuka, H., Wei, W., Acetylation-dependent regulation of MDM2 E3 ligase activity dictates its oncogenic function. Sci. Signal., 10, 2017, eaai8026, 10.1126/scisignal.aai8026.
47. Brooks, C.L., Gu, W., p53 ubiquitination: Mdm2 and beyond. Mol. Cell 21 (2006), 307–315, 10.1016/j.molcel.2006.01.020.
48. Meulmeester, E., Maurice, M.M., Boutell, C., Teunisse, A.F.A.S.A.S., Ovaa, H., Abraham, T.E., Dirks, R.W., Jochemsen, A.G., Loss of HAUSP-mediated deubiquitination contributes to DNA damage-induced destabilization of Hdmx and Hdm2. Mol. Cell 18 (2005), 565–576, 10.1016/j.molcel.2005.04.024.
49. Ma, J., Martin, J.D., Xue, Y., Lor, L.A., Kennedy-Wilson, K.M., Sinnamon, R.H., Ho, T.F., Zhang, G., Schwartz, B., Tummino, P.J., Lai, Z., C-terminal region of USP7/HAUSP is critical for deubiquitination activity and contains a second mdm2/p53 binding site. Arch. Biochem. Biophys. 503 (2010), 207–212, 10.1016/j.abb.2010.08.020.
50. Brazhnik, P., Kohn, K.W., HAUSP-regulated switch from auto- to p53 ubiquitination by Mdm2 (in silico discovery). Math. Biosci. 210 (2007), 60–77, 10.1016/j.mbs.2007.05.005.
51. Tavana, O., Gu, W., Modulation of the p53/MDM2 interplay by HAUSP inhibitors. J. Mol. Cell Biol. 9 (2017), 45–52, 10.1093/jmcb/mjw049.
52. Epping, M.T., Meijer, L.A.T., Krijgsman, O., Bos, J.L., Pandolfi, P.P., Bernards, R., TSPYL5 suppresses p53 levels and function by physical interaction with USP7. Nat. Cell Biol. 13 (2011), 102–108, 10.1038/ncb2142.
53. Zhang, J., Cao, M., Dong, J., Li, C., Xu, W., Zhan, Y., Wang, X., Yu, M., Ge, C., Ge, Z., Yang, X., ABRO1 suppresses tumourigenesis and regulates the DNA damage response by stabilizing p53. Nat. Commun., 5, 2014, 5059, 10.1038/ncomms6059.
54. Song, M.S., Song, S.J., Kim, S.Y., Oh, H.J., Lim, D.-S., The tumour suppressor RASSF1A promotes MDM2 self-ubiquitination by disrupting the MDM2–DAXX–HAUSP complex. EMBO J. 27 (2008), 1863–1874, 10.1038/emboj.2008.115.
55. Song, M.S., Salmena, L., Carracedo, A., Egia, A., Lo-Coco, F., Teruya-Feldstein, J., Pandolfi, P.P., The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network. Nature 455 (2008), 813–817, 10.1038/nature07290.
56. Du, Z., Song, J., Wang, Y., Zhao, Y., Guda, K., Yang, S., Kao, H.-Y.H.-Y., Xu, Y., Willis, J., Markowitz, S.D., Sedwick, D., Ewing, R.M., Wang, Z., DNMT1 stability is regulated by proteins coordinating deubiquitination and acetylation-driven ubiquitination. Sci. Signal., 3, 2010, ra80, 10.1126/scisignal.2001462.
57. Qin, W., Leonhardt, H., Spada, F., Usp7 and Uhrf1 control ubiquitination and stability of the maintenance DNA methyltransferase Dnmt1. J. Cell. Biochem. 112 (2011), 439–444, 10.1002/jcb.22998.
58. Felle, M., Joppien, S., Németh, A., Diermeier, S., Thalhammer, V., Dobner, T., Kremmer, E., Kappler, R., Längst, G., Nemeth, A., Diermeier, S., Thalhammer, V., Dobner, T., Kremmer, E., Kappler, R., Langst, G., The USP7/Dnmt1 complex stimulates the DNA methylation activity of Dnmt1 and regulates the stability of UHRF1. Nucleic Acids Res. 39 (2011), 8355–8365, 10.1093/nar/gkr528.
59. Rothbart, S.B., Dickson, B.M., Ong, M.S., Krajewski, K., Houliston, S., Kireev, D.B., Arrowsmith, C.H., Strahl, B.D., Multivalent histone engagement by the linked tandem Tudor and PHD domains of UHRF1 is required for the epigenetic inheritance of DNA methylation. Genes Dev. 27 (2013), 1288–1298, 10.1101/gad.220467.113.
60. Bronner, C., Control of DNMT1 abundance in epigenetic inheritance by acetylation, Ubiquitylation, and the histone code. Sci. Signal., 4, 2011, pe3, 10.1126/scisignal.2001764.
61. Ma, H., Chen, H., Guo, X., Wang, Z., Sowa, M.E., Zheng, L., Hu, S., Zeng, P., Guo, R., Diao, J., Lan, F., Harper, J.W., Shi, Y.G., Xu, Y., Shi, Y., M phase phosphorylation of the epigenetic regulator UHRF1 regulates its physical association with the deubiquitylase USP7 and stability. Proc. Natl. Acad. Sci. 109 (2012), 4828–4833, 10.1073/pnas.1116349109.
62. Meng, H., Harrison, D.J., Meehan, R.R., MBD4 interacts with and recruits USP7 to heterochromatic foci. J. Cell. Biochem. 116 (2015), 476–485, 10.1002/jcb.25001.
63. Hao, Y.-H., Doyle, J.M., Ramanathan, S., Gomez, T.S., Jia, D., Xu, M., Chen, Z.J., Billadeau, D.D., Rosen, M.K., Potts, P.R., Regulation of WASH-dependent actin polymerization and protein trafficking by ubiquitination. Cell 152 (2013), 1051–1064, 10.1016/j.cell.2013.01.051.
64. Doyle, J.M., Gao, J., Wang, J., Yang, M., Potts, P.R., MAGE-RING protein complexes comprise a family of E3 ubiquitin ligases. Mol. Cell 39 (2010), 963–974, 10.1016/j.molcel.2010.08.029.
65. Schaaf, C.P., Gonzalez-Garay, M.L., Xia, F., Potocki, L., Gripp, K.W., Zhang, B., Peters, B.A., McElwain, M.A., Drmanac, R., Beaudet, A.L., Caskey, C.T., Yang, Y., Truncating mutations of MAGEL2 cause Prader-Willi phenotypes and autism. Nat. Genet. 45 (2013), 1405–1408, 10.1038/ng.2776.
66. Mercer, R.E., Kwolek, E.M., Bischof, J.M., van Eede, M., Henkelman, R.M., Wevrick, R., Regionally reduced brain volume, altered serotonin neurochemistry, and abnormal behavior in mice null for the circadian rhythm output gene Magel2. Am. J. Med. Genet. B Neuropsychiatr. Genet. 150B (2009), 1085–1099, 10.1002/ajmg.b.30934.
67. Bertrand, M.J.M., Milutinovic, S., Dickson, K.M., Ho, W.C., Boudreault, A., Durkin, J., Gillard, J.W., Jaquith, J.B., Morris, S.J., Barker, P.A., cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination. Mol. Cell 30 (2008), 689–700, 10.1016/j.molcel.2008.05.014.
68. Conwell, S.E., White, A.E., Harper, J.W., Knipe, D.M., Identification of TRIM27 as a novel degradation target of Herpes simplex virus 1 ICP0. J. Virol. 89 (2015), 220–229, 10.1128/JVI.02635-14.
69. Pozhidaeva, A.K., Mohni, K.N., Dhe-Paganon, S., Arrowsmith, C.H., Weller, S.K., Korzhnev, D.M., Bezsonova, I., Structural characterization of interaction between human ubiquitin specific protease 7 and immediate early protein ICP0 of Herpes simplex virus-1. J. Biol. Chem. 290 (2015), 22907–22918, 10.1074/jbc.M115.664805.
70. Everett, R.D., Meredith, M., Orr, A., Cross, A., Kathoria, M., Parkinson, J., A novel ubiquitin-specific protease is dynamically associated with the PML nuclear domain and binds to a herpesvirus regulatory protein. EMBO J. 16 (1997), 1519–1530, 10.1093/emboj/16.7.1519.
71. Lanfranca, M.P., Mostafa, H.H., Davido, D.J., HSV-1 ICP0: an E3 ubiquitin ligase that counteracts host intrinsic and innate immunity. Cell 3 (2014), 438–454, 10.3390/cells3020438.
72. Boutell, C., Canning, M., Orr, A., Everett, R.D., Reciprocal activities between Herpes simplex virus type 1 regulatory protein ICP0, a ubiquitin E3 ligase, and ubiquitin-specific protease USP7. J. Virol. 79 (2005), 12,342–12,354, 10.1128/JVI.79.19.12342-12354.2005.
73. Daubeuf, S., Singh, D., Tan, Y., Liu, H., Federoff, H.J., Bowers, W.J., Tolba, K., HSV ICP0 recruits USP7 to modulate TLR-mediated innate response. Blood 113 (2009), 3264–3275, 10.1182/blood-2008-07-168203.
74. Canning, M., Boutell, C., Parkinson, J., Everett, R.D., A RING finger ubiquitin ligase is protected from autocatalyzed ubiquitination and degradation by binding to ubiquitin-specific protease USP7. J. Biol. Chem. 279 (2004), 38,160–38,168, 10.1074/jbc.M402885200.
75. Boutell, C., Everett, R.D., Herpes simplex virus type 1 infection induces the stabilization of p53 in a USP7- and ATM-independent manner. J. Virol. 78 (2004), 8068–8077, 10.1128/JVI.78.15.8068-8077.2004.
76. Zlatanou, A., Sabbioneda, S., Miller, E.S., Greenwalt, A., Aggathanggelou, A., Maurice, M.M., Lehmann, A.R., Stankovic, T., Reverdy, C., Colland, F., Vaziri, C., Stewart, G.S., USP7 is essential for maintaining Rad18 stability and DNA damage tolerance. Oncogene 35 (2016), 965–976, 10.1038/onc.2015.149.
77. Qian, J., Pentz, K., Zhu, Q., Wang, Q., He, J., Srivastava, A.K., Wani, A.A., USP7 modulates UV-induced PCNA monoubiquitination by regulating DNA polymerase eta stability. Oncogene 34 (2015), 4791–4796, 10.1038/onc.2014.394.
78. Kashiwaba, S., Kanao, R., Masuda, Y., Kusumoto-Matsuo, R., Hanaoka, F., Masutani, C., USP7 is a suppressor of PCNA ubiquitination and oxidative-stress-induced mutagenesis in human cells. Cell Rep. 13 (2015), 2072–2080, 10.1016/j.celrep.2015.11.014.
79. Hoege, C., Pfander, B., Moldovan, G.-L., Pyrowolakis, G., Jentsch, S., RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO. Nature 419 (2002), 135–141, 10.1038/nature00991.
80. Zhu, Q., Sharma, N., He, J., Wani, G., Wani, A.A., USP7 deubiquitinase promotes ubiquitin-dependent DNA damage signaling by stabilizing RNF168*. Cell Cycle 14 (2015), 1413–1425, 10.1080/15384101.2015.1007785.
81. An, L., Jiang, Y., Ng, H.H.W., Man, E.P.S., Chen, J., Khoo, U.-S., Gong, Q., Huen, M.S.Y., Dual-utility NLS drives RNF169-dependent DNA damage responses. Proc. Natl. Acad. Sci. U. S. A., 2017 201,616,602 http://dx.doi.org/10.1073/pnas.1616602114.
82. Maertens, G.N., El Messaoudi-Aubert, S., Elderkin, S., Hiom, K., Peters, G., Ubiquitin-specific proteases 7 and 11 modulate polycomb regulation of the INK4a tumour suppressor. EMBO J. 29 (2010), 2553–2565, 10.1038/emboj.2010.129.
83. de Bie, P., Zaaroor-Regev, D., Ciechanover, A., Regulation of the polycomb protein RING1B ubiquitination by USP7. Biochem. Biophys. Res. Commun. 400 (2010), 389–395, 10.1016/j.bbrc.2010.08.082.
84. Gao, Z., Zhang, J., Bonasio, R., Strino, F., Sawai, A., Parisi, F., Kluger, Y., Reinberg, D., PCGF homologs, CBX proteins, and RYBP define functionally distinct PRC1 family complexes. Mol. Cell 45 (2012), 344–356, 10.1016/j.molcel.2012.01.002.
85. Lecona, E., Narendra, V., Reinberg, D., USP7 cooperates with SCML2 to regulate the activity of PRC1. Mol. Cell. Biol. 35 (2015), 1157–1168, 10.1128/MCB.01197-14.
86. Luo, M., Zhou, J., Leu, N.A., Abreu, C.M., Wang, J., Anguera, M.C., de Rooij, D.G., Jasin, M., Wang, P.J., Polycomb protein SCML2 associates with USP7 and counteracts histone H2A ubiquitination in the XY chromatin during male meiosis. PLoS Genet., 11, 2015, e1004954, 10.1371/journal.pgen.1004954.
87. Bonasio, R., Lecona, E., Narendra, V., Voigt, P., Parisi, F., Kluger, Y., Reinberg, D., Interactions with RNA direct the polycomb group protein SCML2 to chromatin where it represses target genes. elife, 3, 2014, e02637.
88. van der Knaap, J.A., Kumar, B.R.P., Moshkin, Y.M., Langenberg, K., Krijgsveld, J., Heck, A.J.R., Karch, F., Verrijzer, C.P., GMP synthetase stimulates histone H2B deubiquitylation by the epigenetic silencer USP7. Mol. Cell 17 (2005), 695–707, 10.1016/j.molcel.2005.02.013.
89. Sarkari, F., Sanchez-Alcaraz, T., Wang, S., Holowaty, M.N., Sheng, Y., Frappier, L., EBNA1-mediated recruitment of a histone H2B deubiquitylating complex to the Epstein-Barr virus latent origin of DNA replication. PLoS Pathog., 5, 2009, e1000624, 10.1371/journal.ppat.1000624.
90. Nguyen, L.K., Muñoz-García, J., Maccario, H., Ciechanover, A., Kolch, W., Kholodenko, B.N., Switches, excitable responses and oscillations in the Ring1B/Bmi1 ubiquitination system. PLoS Comput. Biol., 7, 2011, e1002317, 10.1371/journal.pcbi.1002317.
91. Hu, X., Kim, J.A., Castillo, A., Huang, M., Liu, J., Wang, B., NBA1/MERIT40 and BRE interaction is required for the integrity of two distinct deubiquitinating enzyme BRCC36-containing complexes. J. Biol. Chem. 286 (2011), 11,734–11,745, 10.1074/jbc.M110.200857.
92. Feng, L., Wang, J., Chen, J., The Lys63-specific deubiquitinating enzyme BRCC36 is regulated by two scaffold proteins localizing in different subcellular compartments. J. Biol. Chem. 285 (2010), 30,982–30,988, 10.1074/jbc.M110.135392.
93. Wang, B., Matsuoka, S., Ballif, B.A., Zhang, D., Smogorzewska, A., Gygi, S.P., Elledge, S.J., Abraxas and RAP80 form a BRCA1 protein complex required for the DNA damage response. Science 316 (2007), 1194–1198, 10.1126/science.1139476.
94. Coleman, K.A., Greenberg, R.A., The BRCA1-RAP80 complex regulates DNA repair mechanism utilization by restricting end resection. J. Biol. Chem. 286 (2011), 13,669–13,680, 10.1074/jbc.M110.213728.
95. van der Knaap, J.A., Kozhevnikova, E., Langenberg, K., Moshkin, Y.M., Verrijzer, C.P., Biosynthetic enzyme GMP synthetase cooperates with ubiquitin-specific protease 7 in transcriptional regulation of ecdysteroid target genes. Mol. Cell. Biol. 30 (2010), 736–744, 10.1128/MCB.01121-09.
96. Reddy, B.A., van der Knaap, J.A., Bot, A.G.M., Mohd-Sarip, A., Dekkers, D.H.W., Timmermans, M.A., Martens, J.W.M., Demmers, J.A.A., Verrijzer, C.P., Nucleotide biosynthetic enzyme GMP synthase is a TRIM21-controlled relay of p53 stabilization. Mol. Cell 53 (2014), 458–470, 10.1016/j.molcel.2013.12.017.
97. Schwertman, P., Vermeulen, W., Marteijn, J.A., UVSSA and USP7, a new couple in transcription-coupled DNA repair. Chromosoma 122 (2013), 275–284, 10.1007/s00412-013-0420-2.
98. Schwertman, P., Lagarou, A., Dekkers, D.H.W., Raams, A., van der Hoek, A.C., Laffeber, C., Hoeijmakers, J.H.J., Demmers, J.A.A., Fousteri, M., Vermeulen, W., Marteijn, J.A., UV-sensitive syndrome protein UVSSA recruits USP7 to regulate transcription-coupled repair. Nat. Genet. 44 (2012), 598–602, 10.1038/ng.2230.
99. Higa, M., Zhang, X., Tanaka, K., Saijo, M., Stabilization of ultraviolet (UV)-stimulated scaffold protein A by interaction with ubiquitin-specific peptidase 7 is essential for transcription-coupled nucleotide excision repair. J. Biol. Chem. 291 (2016), 13,771–13,779, 10.1074/jbc.M116.724658.
100. Nathan, J.A., Sengupta, S., Wood, S.A., Admon, A., Markson, G., Sanderson, C., Lehner, P.J., The ubiquitin E3 ligase MARCH7 is differentially regulated by the deubiquitylating enzymes USP7 and USP9X. Traffic 9 (2008), 1130–1145, 10.1111/j.1600-0854.2008.00747.x.
101. Ma, P., Yang, X., Kong, Q., Li, C., Yang, S., Li, Y., Mao, B., The ubiquitin ligase RNF220 enhances canonical Wnt signaling through USP7-mediated deubiquitination of β-catenin. Mol. Cell. Biol. 34 (2014), 4355–4366, 10.1128/MCB.00731-14.
102. Wheaton, K., Sarkari, F., Stanly Johns, B., Davarinejad, H., Egorova, O., Kaustov, L., Raught, B., Saridakis, V., Sheng, Y., UbE2E1/UBCH6 is a critical in vivo E2 for the PRC1 catalyzed ubiquitination of H2A at K119. J. Biol. Chem. 292 (2017), 2893–2902, 10.1074/jbc.M116.749564.
103. Holowaty, M.N., Sheng, Y., Nguyen, T., Arrowsmith, C., Frappier, L., Protein interaction domains of the ubiquitin-specific protease, USP7/HAUSP. J. Biol. Chem. 278 (2003), 47,753–47,761, 10.1074/jbc.M307200200.
104. Lee, H.-R., Choi, W.-C., Lee, S., Hwang, J., Hwang, E., Guchhait, K., Haas, J., Toth, Z., Jeon, Y.H., Oh, T.-K., Kim, M.H., Jung, J.U., Bilateral inhibition of HAUSP deubiquitinase by a viral interferon regulatory factor protein. Nat. Struct. Mol. Biol. 18 (2011), 1336–1344, 10.1038/nsmb.2142.
105. Jäger, W., Santag, S., Weidner-Glunde, M., Gellermann, E., Kati, S., Pietrek, M., Viejo-Borbolla, A., Schulz, T.F., The ubiquitin-specific protease USP7 modulates the replication of Kaposi's sarcoma-associated herpesvirus latent episomal DNA. J. Virol. 86 (2012), 6745–6757, 10.1128/JVI.06840-11.
106. van Loosdregt, J., Fleskens, V., Fu, J., Brenkman, A.B., Bekker, C.P.J., Pals, C.E.G.M., Meerding, J., Berkers, C.R., Barbi, J., Gröne, A., Sijts, A.J.A.M., Maurice, M.M., Kalkhoven, E., Prakken, B.J., Ovaa, H., Pan, F., Zaiss, D.M.W., Coffer, P.J., Stabilization of the transcription factor Foxp3 by the deubiquitinase USP7 increases Treg-cell-suppressive capacity. Immunity 39 (2013), 259–271.
107. Reverdy, C., Conrath, S., Lopez, R., Planquette, C., Atmanene, C., Collura, V., Harpon, J., Battaglia, V., Vivat, V., Sippl, W., Colland, F., Discovery of specific inhibitors of human USP7/HAUSP deubiquitinating enzyme. Chem. Biol. 19 (2012), 467–477, 10.1016/j.chembiol.2012.02.007.
108. Colland, F., Formstecher, E., Jacq, X., Reverdy, C., Planquette, C., Conrath, S., Trouplin, V., Bianchi, J., Aushev, V.N., Camonis, J., Calabrese, A., Borg-Capra, C., Sippl, W., Collura, V., Boissy, G., Rain, J.-C., Guedat, P., Delansorne, R., Daviet, L., Small-molecule inhibitor of USP7/HAUSP ubiquitin protease stabilizes and activates p53 in cells. Mol. Cancer Ther. 8 (2009), 2286–2295, 10.1158/1535-7163.MCT-09-0097.
109. Dar, A., Shibata, E., Dutta, A., Deubiquitination of Tip60 by USP7 determines the activity of the p53-dependent apoptotic pathway. Mol. Cell. Biol. 33 (2013), 3309–3320, 10.1128/MCB.00358-13.
110. Altun, M., Kramer, H.B., Willems, L.I., McDermott, J.L., Leach, C.A., Goldenberg, S.J., Kumar, K.G.S.G.S., Konietzny, R., Fischer, R., Kogan, E., Mackeen, M.M., McGouran, J., Khoronenkova, S.V., Parsons, J.L., Dianov, G.L., Nicholson, B., Kessler, B.M., Activity-based chemical proteomics accelerates inhibitor development for deubiquitylating enzymes. Chem. Biol. 18 (2011), 1401–1412, 10.1016/j.chembiol.2011.08.018.
111. Weinstock, J., Wu, J., Cao, P., Kingsbury, W.D., McDermott, J.L., Kodrasov, M.P., McKelvey, D.M., Suresh Kumar, K.G., Goldenberg, S.J., Mattern, M.R., Nicholson, B., Selective dual inhibitors of the cancer-related deubiquitylating proteases USP7 and USP47. ACS Med. Chem. Lett. 3 (2012), 789–792, 10.1021/ml200276j.
112. Chen, C., Song, J., Wang, J., Xu, C., Chen, C., Gu, W., Sun, H., Wen, X., Synthesis and biological evaluation of thiazole derivatives as novel USP7 inhibitors. Bioorg. Med. Chem. Lett. 27 (2017), 845–849, 10.1016/j.bmcl.2017.01.018.
113. Zhang, Y., Zhou, L., Rouge, L., Phillips, A.H., Lam, C., Liu, P., Sandoval, W., Helgason, E., Murray, J.M., Wertz, I.E., Corn, J.E., Conformational stabilization of ubiquitin yields potent and selective inhibitors of USP7. Nat. Chem. Biol. 9 (2013), 51–58, 10.1038/nchembio.1134.
114. Ernst, A., Avvakumov, G., Tong, J., Fan, Y., Zhao, Y., Alberts, P., Persaud, A., Walker, J.R., Neculai, A.-M., Neculai, D., Vorobyov, A., Garg, P., Beatty, L., Chan, P.-K., Juang, Y.-C., Landry, M.-C., Yeh, C., Zeqiraj, E., Karamboulas, K., Allali-Hassani, A., Vedadi, M., Tyers, M., Moffat, J., Sicheri, F., Pelletier, L., Durocher, D., Raught, B., Rotin, D., Yang, J., Moran, M.F., Dhe-Paganon, S., Sidhu, S.S., A strategy for modulation of enzymes in the ubiquitin system. Science 339 (2013), 590–595, 10.1126/science.1230161.
115. Fan, Y.-H., Cheng, J., Vasudevan, S.A., Dou, J., Zhang, H., Patel, R.H., Ma, I.T., Rojas, Y., Zhao, Y., Yu, Y., Zhang, H., Shohet, J.M., Nuchtern, J.G., Kim, E.S., Yang, J., USP7 inhibitor P22077 inhibits neuroblastoma growth via inducing p53-mediated apoptosis. Cell Death Dis., 4, 2013, e867, 10.1038/cddis.2013.400.
116. Lee, G., Oh, T.-I., Um, K.B., Yoon, H., Son, J., Kim, B.M., Kim, H.-I., Kim, H., Kim, Y.J., Lee, C.-S., Lim, J.-H., Small-molecule inhibitors of USP7 induce apoptosis through oxidative and endoplasmic reticulum stress in cancer cells. Biochem. Biophys. Res. Commun. 470 (2016), 181–186, 10.1016/j.bbrc.2016.01.021.